February 24, 2012
Daiichi Sankyo and Terumo Corporation announced on February 23 that they concluded a basic agreement to codevelop a new vaccine utilizing Terumo’s intradermal injection device. The two companies, which have been conducting joint research for an intradermal influenza vaccine, will...read more